Citation: Sa. Brada et al., THE USE OF REMIFENTANIL INFUSION TO FACILITATE EPIDURAL CATHETER PLACEMENT IN A PARTURIENT - A CASE-REPORT WITH PHARMACOKINETIC SIMULATIONS, International journal of obstetric anesthesia, 7(2), 1998, pp. 124-127
Citation: E. Smyth et Td. Egan, APNEIC OXYGENATION ASSOCIATED WITH PATIENT-CONTROLLED ANALGESIA, Journal of clinical anesthesia, 10(6), 1998, pp. 499-501
Citation: Kb. Johnson et Td. Egan, REMIFENTANIL AND PROPOFOL COMBINATION FOR AWAKE CRANIOTOMY - CASE-REPORT WITH PHARMACOKINETIC SIMULATIONS, Journal of neurosurgical anesthesiology, 10(1), 1998, pp. 25-29
Authors:
EGAN TD
KERN SE
WHITE JL
WELLS DT
JOHNSON JO
Citation: Td. Egan et al., ASSESSING HYPNOTIC AND OPIOID INTERACTIONS IN VOLUNTEERS USING SURROGATE MEASURES - A NEW STUDY PARADIGM, Anesthesiology, 89(3A), 1998, pp. 483-483
Authors:
STREISAND JB
BUSCH MA
EGAN TD
SMITH BG
GAY M
PACE NL
Citation: Jb. Streisand et al., DOSE PROPORTIONALITY AND PHARMACOKINETICS OF ORAL TRANSMUCOSAL FENTANYL CITRATE, Anesthesiology, 88(2), 1998, pp. 305-309
Citation: Pl. Bailey et Td. Egan, THE SUCCESSFUL IMPLEMENTATION OF PHARMACEUTICAL PRACTICE GUIDELINES -FAR FROM CONVINCING, Anesthesiology, 87(6), 1997, pp. 1583-1584
Citation: J. Lu et al., PROSPECTIVE PHARMACOKINETIC AND PHARMACODYNAMIC VALIDATION OF THE CONTEXT-SENSITIVE HALF-TIME FOR ALFENTANIL, Anesthesiology, 87(3), 1997, pp. 347-347
Authors:
MINTO CF
SCHNIDER TW
EGAN TD
YOUNGS E
LEMMENS HJM
GAMBUS PL
BILLARD V
HOKE JF
MOORE KHP
HERMANN DJ
MUIR KT
MANDEMA JW
SHAFER SL
Citation: Cf. Minto et al., INFLUENCE OF AGE AND GENDER ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF REMIFENTANIL .1. MODEL DEVELOPMENT, Anesthesiology, 86(1), 1997, pp. 10-23
Citation: Td. Egan et al., USING THE ELECTROENCEPHALOGRAPHIC (EEG) FINGERPRINT TO DEFINE THE CLINICAL PHARMACODYNAMICS (PD) OF A NOVEL OPIOID - APPLICATION TO REMIFENTANIL (REMI), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 1-1
Citation: Td. Egan et al., THE EEG VERSUS CLINICAL MEASURES OF OPIOID POTENCY - DEFINING THE EEG-CLINICAL POTENCY FINGERPRINT WITH APPLICATION TO REMIFENTANIL, Anesthesiology, 85(3A), 1996, pp. 349-349
Authors:
EGAN TD
MINTO CF
HERMANN DJ
BARR J
MUIR KT
SHAFER SL
Citation: Td. Egan et al., REMIFENTANIL VERSUS ALFENTANIL - COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY ADULT MALE-VOLUNTEERS, Anesthesiology, 84(4), 1996, pp. 821-833
Citation: Td. Egan, STEREOCHEMISTRY AND ANESTHETIC PHARMACOLOGY - JOINING HANDS WITH THE MEDICINAL CHEMISTS, Anesthesia and analgesia, 83(3), 1996, pp. 447-450
Citation: Nf. Jensen et Td. Egan, DEFINING THE CONCENTRATION-EFFECT RELATIONSHIP OF VOLATILE ANESTHETICS IN VESSELS USING AN IN-VITRO NONSTEADY-STATE TECHNIQUE, The Journal of pharmacology and experimental therapeutics, 274(1), 1995, pp. 293-299
Citation: Hjm. Lemmens et al., PHARMACOKINETIC DYNAMIC ASSESSMENT IN DRUG DEVELOPMENT - APPLICATION TO THE INVESTIGATIONAL OPIOID MIRFENTANIL, Anesthesia and analgesia, 80(6), 1995, pp. 1206-1211
Authors:
EGAN TD
LEMMENS HJM
FISET P
HERMANN DJ
MUIR KT
STANSKI DR
SHAFER SL
Citation: Td. Egan et al., THE PHARMACOKINETICS OF THE NEW SHORT-ACTING OPIOID REMIFENTANIL (GI87084B) IN HEALTHY ADULT MALE-VOLUNTEERS, Anesthesiology, 79(5), 1993, pp. 881-892